2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials 2013

  • Conference Call
  • OMICS Publishing Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials 2013 during November 18-19, 2013 at San Antonio, USA.

    The first International Conference and Exhibition on Pharmacovigilance & Clinical Trials was held in DoubleTree by Hilton, Chicago North shore, USA, October 21-23, 2012 with a theme "Safer Drugs and Good Clinical Practice" which brought together large and medium pharmaceutical, biotech companies, leading Universities, Clinical research institutions and dignitaries from Quality & Regulatory departments of FDA.

    OMICS Group proudly announces, 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials, which will bring together a unique and International mix of Pharmaceutical, Biotech and Clinical research companies, leading Universities and Research Institutes working in the field of Pharmacovigilance and drug safety, making the conference a perfect platform to share experience, foster collaborations across industry and academia and share emerging scientific updates across the globe by means of thought provoking Keynote presentations, oral talks and poster presentations opportunities.

    Special OMICS Journals

    All accepted abstracts will be published in either the Journal of Pharmacovigilance, Journal of Clinical & Experimental Pharmacology or Journal of Clinical Trials.

    Conference Topics

    2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials, will be organized around the theme "Monitoring the Challenges in Drugs safety and Risk Management to ensure the Safer Drugs to the Market." Pharmacovigilance-2013 is comprised of 10 tracks and 43 sessions designed to offer comprehensive sessions that address current issues in 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials. Submit your abstract to any of the following tracks. All related abstracts are accepted.

    Pharmacovigilance and its Challenges

    • Role of pharmacovigilance in health regulation
    • International collaboration and new pharmacovigilance legislation
    • Role of pharma industries in the improvement of pharmacovigilance system
    • Fatality of pharmacovigilance failure
    • Detection & evaluation of drug safety signals

    Role of Clinical Trials

    • Data collection and quality control
    • Alternative trials design and models
    • Multi center trials and monitoring
    • Multi center trials and monitoring

    Clinical Trials on Diseases

    • Emerging technology in clinical trials
    • Recent clinical trials on Parkinsons disease
    • Clinical trials on cancer
    • Applications of biomarkers in clinical trials
    • Emerging technology in clinical trials

    Adverse Drug Reactions

    • Assessing & reporting adverse drug reactions
    • Reduction of adverse drug reaction by nano technology
    • Expected and un-expected drug reactions and its reporting
    • Drugs in human pregnancy and nursing
    • Pharmacotherapy and Pharmacogenomics
    • Post marketing reports on adverse effects

    Drug Interactions

    • Advances of pharmacokinetic interactions
    • Advances of pharmacodynamic interactions
    • Drug and substance abuse
    • Drug-drug interactions
    • Pharmacoenvironmentology

    Pharmacy Practices and Its Challenges

    • Pharmacy practice and its guidelines
    • Challenges in compounding and dispensing practice
    • Drug toxicity and drug safety measures
    • Pharmacoepidemiology of drug shortages

    Regulatory Affairs

    • Role of regulatory affairs in pharmacovigilance
    • Role of regulatory agencies in safe medicines and medical devices
    • Risk minimization tools

    Risk Management: New Approaching Paradigm for Pharmacovigilance

    • Information technology in pharmacovigilance and promoting companies
    • Review of softwares used in pharmacovigilance and clinical trials
    • Risk communication: Interface between pharmacovigilance, sales and marketing
    • Risk management versus recent market withdrawal
    • Monitoring unlicensed, off labels and orphan drugs

    Clinical Research and Statistics

    • Guidelines for clinical research and its statistics
    • Advanced Information technology in clinical trials and promoting companies
    • Data mining concepts and techniques

    Strategies for Growth in Pharma Environment

    • Strategic development towards FDA approval
    • Advances in changing pharmacovigilance regulation system
    • Post market product surveillances
    starting: ending: 19.11.2013 Location: , Category:


    Conference START 19.11.2013 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address 611 NW Interstate 410 Loop Frontage Road Category Organiser More Info Conference Website

    Further interesting Conferences